<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
Notification of Late Filing
Commission File Number 0-20356
(Check One): [X] Form 10-K and Form 10-KSB [ ] Form 11-K
[ ] Form 20-F [ ] Form 10-Q and Form 10-QSB [ ] Form N-SAR
For Period Ended: December 31, 1998
[ ] Transition Report on Form 10-K and Form 10-KSB [ ] Transition Report on Form
20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10Q and
Form 10-QSB [ ] Transition Report on Form N-SAR
For the Transition Period Ended: __________________________
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------
Part I
Registrant Information
Full Name of Registrant: Medical Industries of America, Inc.
Former Name if Applicable: ____________________________
Address of Principal Executive Office: 1903 S. Congress Avenue, Suite
400
City, State and Zip Code: Boynton Beach, Florida 33426
<PAGE>
Part II
Rule 12b-25(b) and (c)
- --------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the
following should be completed. (Check appropriate box.)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report or portion thereof will be filed on or before
the 15th calendar day following the prescribed due date; or the subject
quarterly report or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
Part III
Narrative
State below in reasonable detail the reasons why Forms 10K, 10-KSB, 11-K,
20-F, 10-Q, 10-QSB, N-SAR or the transition report or portion thereof could not
be filed within the prescribed time period.
(Attach extra sheets if needed.)
The Company has not received third-party information in order to
complete its financial statements.
2
<PAGE>
Part IV
Other Information
Name and telephone number of person to contact in regard to this notification:
Arthur P. Kobrin (561) 737-2227
- --------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months or for such
shorter period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s):
[X] Yes [ ] No
Is it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so: Attach an explanation of the anticipated change, both narratively and
quantitively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
MEDICAL INDUSTRIES OF AMERICA, INC.
(Name of Registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 30, 1999 BY: /s/ Arthur P.
Kobrin
Arthur P. Kobrin
Chief Financial Officer
